Letters Section Editor: Stephen J. Lurie,
MD, PhD, Senior Editor.
To the Editor: Dr Weinberger and colleagues1 found that patients with asthma who received pharmaceutical
care experienced more breathing-related ED visits. It is possible that patients'
interactions with the pharmacists resulted in constant reminder of the morbidity
of uncontrolled asthma and resulted in a need to seek definitive treatment
and further reassurance. The nature of the conversation with the pharmacist
could have provided the patients with reinforcement of disease-related symptoms
and increased reassurance of their own understanding of the disease. In any
event, results suggest that patient-physician interaction may not be adequate
to educate patients about chronic disease. Similar trends of improved care
of heart failure management with the involvement of pharmacists have been
Amit K. Ghosh. Pharmacist Care for Reactive Airway DiseasePharmacist Care for Reactive Airway Disease. JAMA. 2003;289(9):1103–1106. doi:10.1001/jama.289.9.1103-a